
Zenas BioPharma, Inc.
USD32.36
+1.66 (+5.41%)
CEO
Leon Oliver Moulder Jr.
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.37
Prev. Close
$30.70
Day Low
$30.77
Day High
$34.03
52W Low
$13.50
52W High
$44.60
Market Cap
$1.44B
Volume
1.62M
| 17 Mar 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 17 Mar 2026 | Guggenheim | Buy | Buy | maintain |
| 17 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 6 Jan 2026 | Morgan Stanley | Overweight | Equal Weight | downgrade |
| 22 Dec 2025 | Wedbush | Outperform | Outperform | maintain |
| 13 Nov 2025 | Morgan Stanley | Overweight | Overweight | maintain |